Blanquart, C., Barbier, O., Fruchart, J., Staels, B. & Glineur, C. (2003) Peroxisome proliferator-activated receptors: regulation of transcriptional activities
and roles in inflammation. J. Steroid Biochem. Mol. Biol., 85, 267–273.
Breidert, T., Callebert, J., Heneka, M., Landreth, G., Launay, J. & Hirsch, E.
(2002) Protective action of the peroxisome proliferator-activated receptor-c
agonist pioglitazone in a mouse model of Parkinson's disease. J. Neurochem., 82, 615–624.
Chapelsky, M., Thompson-Culkin, K., Miller, A., Sack, M., Blum, R. & Freed,
M. (2003) Pharmacokinetics of rosiglitazone in patients with varying degrees
of renal insufficiency. J. Clin. Pharmacol., 43, 252–259.
Chawla, A., Barak, Y., Nagy, L., Lioa, D., Tontonoz, P. & Evans, M. (2001)
PPAR-c dependent and independent effects on macrophage gene expression
in lipid metabolism and inflammation. Nat. Med., 7, 48–52.
Combs, C., Johnson, D., Karlo, C., Cannady, S. & Landreth, G. (2000)
Inflammatory mechanisms in Alzheimer's disease: Inhibition of b-amyloid
stimulated proinflammatory responses and neurotoxicity by PPARc agonists.
J. Neurosci., 20, 558–567.
Davies, S., Pontsler, A., Marathe, G., Harrison, K., Murphy, R., Hinshaw, J.,
Prestwich, G., Hilaire, A., Prescott, S., Zimmerman, G. & McIntyre, T.
(2001) Oxidized alkyl phospholidids are specific high affinity peroxisome
proliferator-activated receptor gamma ligands and agonists. J. Biol. Chem.,
276, 16015–16023.
Daynes, R. & Jones, D. (2002) Emerging roles of PPARs in inflammation and
immunity. Nat. Rev. Immunol., 2, 748–759.
Diab, A., Deng, C., Smith, J., Hussain, R., Phanavanh, B., Lovett-Racke, A.,
Drew, P. & Racke, M. (2002) Peroxisome proliferator-activated receptor-c
agonist 15-deoxy-D12,14-prostaglandin J2 ameliorates experimental autoimmune encephalomyelitis. J. Immunol., 168, 2508–2515.
Diep, Q. & Schiffrin, E. (2001) Increased expression of peroxisome
proliferator-activated receptor-a and -c in blood vessels of spontaneously
hypertensive rats. Hypertension, 38, 249–254.
Duverger, D. & MacKenzie, E. (1988) The quantification of cerebral
infarction following ischemia in the rat: influence of strain, arterial
pressure, blood glucose concentration, and age. J. Cereb. Blood Flow
Metab., 8, 449–461.
Feinstein, D., Galea, E., Gavrilyuk, V., Brosnan, C., Whitacre, C., DumitrescuOzimek, L., Landreth, G., Pershadsingh, H., Weinberg, G. & Heneka, M.
(2002) Peroxisome proliferator-activated receptor-c agonists prevent experimental autoimmune encephalomyelitis. Ann. Neurol., 51, 694–702.
Goldberg, I., Soprano, D., Wyatt, M., Vanni, T., Kirchgessner, T. & Schotz, M.
(1989) Localization of lipoprotein lipase mRNA in selected rat tissues.
J. Lipid Res., 30, 1569–1577.
Han, J., Hajjar, D., Zhou, X., Gotto, A. & Nicholson, A. (2002) Regulation of
peroxisome proliferator-activated receptor-c-mediated gene expression.
J. Biol. Chem., 277, 23582–23586.
Hanefeld, M. (2001) Pharmacokinetics and clinical efficacy of pioglitazone. Int.
J. Clin. Pract. Suppl., 121, 19–25.
Heneka, M., Klockgether, T. & Feinstein, D. (2000) Peroxisome proliferatoractivated receptor-gamma ligands reduce neuronal inducible nitric oxide
synthase expression and cell death in vivo. J. Neurosci., 20, 6862–6867.
Heneka, M., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I.,
Kuiperi, C., O'Banion, K., Klockgether, T., Van Leuven, F. & Landreth, G.
(2005) Acute treatment with the PPARc agonist pioglitazone and ibuprofen
reduces inflammation and Ab1–42 levels in PAA V7171 transgenic mice.
Brain, 128, 1442–1453.
Hickenbottom, S., Grotta, J., Strong, R., Denner, L. & Aronowski, J. (2005)
Nuclear factor-kappaB and cell death after experimental intracerebral
hemorrhage in rats. Stroke, 30, 2477–2478.
Huang, J., Welch, J., Ricote, M., Binder, C., Willson, T., Kelly, C., Witztum, J.,
Funk, C., Conrad, D. & Glass, C. (1999) Interleukin-4-dependent production
of PPAR-c ligands in macrophages by 12 / 15-lipoxygenase. Nature, 400,
378–382.
Inestrosa, N., Godoy, J., Quintanilla, R., Koenig, C. & Bronfman, M. (2005)
Peroxisome proliferator-activated receptor c is expressed in hippocampal
neurons and its activation prevents b-amyloid neurodegeneration: role of
Wnt signaling. Exp. Cell Res., 304, 91–104.
Iruretagoyena, M., Sepulveda, S., Lezana, J., Hermoso, M., Bronfman, M.,
Gutierrez, M., Jacobelli, S. & Kalergis, A. (2006) Inhibition of NF-kB
enhances the capacity of immature dendritic cells to induce antigen-specific
tolerance in experimental autoimune encephalomyelitis. J. Pharmacol. Exp.
Ther., 318, 59–67.
Ito, H., Nakano, A., Kinoshita, M. & Matsumori, A. (2003) Pioglitazone, a
peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia / reperfuson injury in a rat model. Lab. Invest., 83, 1715–
1721.
